Back

Riociguat normalizes altered lung expression of serotonin-related genes and renal damage markers in experimental pulmonary hypertension

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Pulmonary hypertension: is it driven by shear or by genes? Pulmonary Hypertension ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Eva Velasova

Faculty Of Pharmacy, Comenius University, Bratislava (Slovakia)

6 More presentations in this session

Presentation thumbnail
An updated meta-analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease
Assistant Professor S. Caravita (Bergamo, IT)
Abstract Slides
Presentation thumbnail
Increased B-type natriuretic peptide is a better predictor of hospital mortality then increased troponin in patients with acute pulmonary embolism
Doctor B. Dzudovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
The crucial role of tricuspid regurgitation in patients with pulmonary arterial hypertension
Doctor M. Moschella (Turin, IT)
Abstract Slides
Presentation thumbnail
Body fluid status in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Mr A. Yogeswaran (Giessen, DE)
Abstract Slides
Presentation thumbnail
First genetic characteristics of Polish patients with idiopathic pulmonary arterial hypertension
Doctor K. Jonas (Krakow, PL)
Abstract Slides

Access the full session

Session thumbnail
Pulmonary hypertension: is it driven by shear or by genes?

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources